Toward simplified oral lipid-based drug delivery using mono-/di-glycerides as single component excipients.
Alexandra-Roxana IlieBrendan T GriffinMaria VertzoniMartin KuentzFilip CuyckensKoen WuytsRuzica KolakovicRené HolmPublished in: Drug development and industrial pharmacy (2020)
The present study demonstrated the benefits of using mono-/di-glycerides as single component excipients in LBDDS to streamline formulation screening and improve oral bioavailability for the three tested poorly water-soluble drugs.